Ad/Pdtm 2026. The findings from nodthera’s study will be presented on friday march 8 at ad/pdtm 2024, the international conference on alzheimer’s and parkinson’s diseases and. We encourage all participants to download the mobile app prior to the conference.
The ad/pd™ conference has become the main event of the year in the field of neurodegenerative diseases, attracting leading medical and scientific professionals from. Striving for a better future for all those affected by neurodegenerative diseases.